BILLS-117hr941ih.pdf

2021 2005 16 June 30, 2025 each calendar year later than 2 years fiscal year 2015 FEBRUARY 8, 2021 2015 each of fiscal years 2016 2026 42 U.S.C. 274k(d)(2 2 years each of fiscal years 2022 each of fiscal years

SESSION H. R. 941 the ‘‘Timely ReAuthoriza-

PO 00000 Frm 00002 PO 00000 Frm 00005 PO 00000 Frm 00003 Fmt PO 00000 Frm 00001 PO 00000 Frm 00006 PO 00000 Frm 00004

the United States the United States of America

IH the Stem Cell Therapeutic and the Stem Cell Therapeutic and Research Act

APPROPRIATIONS.—To

DSK79L0C42PROD SEC Senate the Public Health Service Act Energy and Commerce Program the Committee on Health, Education Labor the Committee on Energy and Commerce THE HOUSE OF REPRESENTATIVES U.S.C. ADVISORY COUNCIL House the Comptroller General Committee Congress House of Representa- Institutes of Health the Advisory Council THE FIELD OF REGENERATIVE NIH the Health Resources and Services Administration the Stem Cell Therapeutic and Research Reauthor- the National Institutes of Health Advisory National Drug Administration Food and Drugs GAO Programs Lends Access

BILIRAKIS MATSUI PINGREE

regenerative stem cell cells therapies advisory council medicine section public institutes service act blood health service tissue field labor pensions